Cargando…

The CURB65 score predicted 180-day mortality of non-small cell lung carcinoma patients with immune checkpoint inhibitor-associated pneumonitis: A pilot retrospective analysis

INTRODUCTION: The immune checkpoint inhibitor-associated pneumonitis (CIP) is a particularly worrisome and potentially lethal form of immune-related adverse events. An objective and evidence-based assessment tool for evaluating the severity of CIP is in urgent need. CURB65 (consciousness, urea nitro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lan, Fen, Fan, Bo, Wang, Lihua, Xia, Lixia, Zhang, Ting, Li, Wen, Mao, Yanxiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376267/ https://www.ncbi.nlm.nih.gov/pubmed/35978832 http://dx.doi.org/10.3389/fonc.2022.927858

Ejemplares similares

Predicting in-hospital death in pneumonic COPD exacerbation via BAP-65, CURB-65 and machine learning
por: Shiroshita, Akihiro, et al.
Publicado: (2022)

Performance of pneumonia severity index and CURB-65 in predicting 30-day mortality in patients with COVID-19
por: Satici, Celal, et al.
Publicado: (2020)

Mortality of Community-Acquired Pneumonia in Korea: Assessed with the Pneumonia Severity Index and the CURB-65 Score
por: Kim, Hye In, et al.
Publicado: (2013)

Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: Derivation of a clinical algorithm
por: Albrich, Werner C, et al.
Publicado: (2011)

Comparing the 4C mortality score for COVID-19 to established scores (CURB65, CRB65, qSOFA, NEWS) for respiratory infection patients
por: Wellbelove, Zoe, et al.
Publicado: (2021)

CURB-65 as a predictor of 30-day mortality in patients hospitalized with COVID-19 in Ecuador: COVID-EC study()
por: Carriel, J., et al.
Publicado: (2022)

Applicability of the CURB-65 pneumonia severity score for outpatient treatment of COVID-19
por: Nguyen, Yann, et al.
Publicado: (2020)

Combined Neutrophil-to-Lymphocyte Ratio and CURB-65 Score as an Accurate Predictor of Mortality for Community-Acquired Pneumonia in the Elderly
por: Feng, Ding-Yun, et al.
Publicado: (2021)

Eosinophil as a biomarker for diagnosis, prediction, and prognosis evaluation of severe checkpoint inhibitor pneumonitis
por: Li, Yanlin, et al.
Publicado: (2022)

Usefulness of the COVID-GRAM and CURB-65 scores for predicting severity in patients with COVID-19
por: Armiñanzas, Carlos, et al.
Publicado: (2021)

Pneumonitis Induced by Immune Checkpoint Inhibitors: From Clinical Data to Translational Investigation
por: Zhu, Shicong, et al.
Publicado: (2020)

External Validation and Recalibration of the CURB-65 and PSI for Predicting 30-Day Mortality and Critical Care Intervention in Multiethnic Patients with COVID-19
por: Elmoheen, Amr, et al.
Publicado: (2021)

Incidence and outcome of immune checkpoint-induced pneumonitis in oncology patients with history of pulmonary disease
por: Allen, Emily, et al.
Publicado: (2023)

Performance of CURB-65 and ISARIC 4C mortality scores for hospitalized patients with confirmed COVID-19 infection in Saudi Arabia
por: Alwazzeh, Marwan Jabr, et al.
Publicado: (2023)

Relationship of platelet counts, platelet volumes, and Curb-65 scores in the prognosis of COVID-19 patients
por: Işler, Yeşim, et al.
Publicado: (2022)

Le score CURB-65 appliqué à la pneumonie COVID-19 : quel apport ?
por: Allouche, A., et al.
Publicado: (2023)

Immune checkpoint inhibitor-related pneumonitis in non-small cell lung cancer: A review
por: Hao, Yuxuan, et al.
Publicado: (2022)

Dosiomics and radiomics to predict pneumonitis after thoracic stereotactic body radiotherapy and immune checkpoint inhibition
por: Kraus, Kim Melanie, et al.
Publicado: (2023)

Differentiation of COVID-19 Pneumonitis and ICI Induced Pneumonitis
por: Dumoulin, Daphne W., et al.
Publicado: (2020)

Risk of Pneumonitis Associated With Immune Checkpoint Inhibitors in Melanoma: A Systematic Review and Network Meta-Analysis
por: Sun, You-Meng, et al.
Publicado: (2021)

Radiation Recall Pneumonitis After Treatment With Checkpoint Blockade Immunotherapy: A Case Series and Review of Literature
por: Riviere, Paul, et al.
Publicado: (2021)

Pneumonia Severity Index and CURB-65 Score Are Good Predictors of Mortality in Hospitalized Patients With SARS-CoV-2 Community-Acquired Pneumonia
por: Bradley, James, et al.
Publicado: (2022)

Peripheral Blood Biomarkers for Early Diagnosis, Severity, and Prognosis of Checkpoint Inhibitor-Related Pneumonitis in Patients With Lung Cancer
por: Lin, Xinqing, et al.
Publicado: (2021)

Predictive factors and prognosis of immune checkpoint inhibitor-related pneumonitis in non-small cell lung cancer patients
por: Liu, Xiaoyu, et al.
Publicado: (2023)

Comparison of CURB-65, PSI, and qSOFA for predicting pneumonia mortality in patients with idiopathic pulmonary fibrosis
por: Yamazaki, Ryo, et al.
Publicado: (2021)

CURB-65 and Long-Term Mortality of Community-Acquired Pneumonia: A Retrospective Study on Hospitalized Patients
por: Carlos, Pedro, et al.
Publicado: (2023)

Expanded CURB-65: a new score system predicts severity of community-acquired pneumonia with superior efficiency
por: Liu, Jin-liang, et al.
Publicado: (2016)

Prognostication of COVID-19 patients using ROX index and CURB-65 score - A retrospective observational study
por: Arora, Poonam, et al.
Publicado: (2022)

The change in age distribution of CAP population in Korea with an estimation of clinical implications of increasing age threshold of current CURB65 and CRB65 scoring system
por: Kim, Byunghyun, et al.
Publicado: (2019)

Comparison of CURB-65 and CRB-65 as predictors of death in community-acquired pneumonia in adults admitted to an ICU
por: Santana, AR, et al.
Publicado: (2013)

Corrigendum: Expanded CURB-65: a new score system predicts severity of community-acquired pneumonia with superior efficiency
por: Liu, Jin-liang, et al.
Publicado: (2018)

The Battle of the Pneumonia Predictors: A Comprehensive Meta-Analysis Comparing the Pneumonia Severity Index (PSI) and the CURB-65 Score in Predicting Mortality and the Need for ICU Support
por: Zaki, Hany A, et al.
Publicado: (2023)

Trastuzumab-Induced Interstitial Pneumonitis
por: Errisuriz, Kimberly, et al.
Publicado: (2023)

DECAF versus CURB-65 to Foresee Mortality among Patients Presenting with an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Ahmed, Naseem, et al.
Publicado: (2020)

The CURB-65 scoring system in severity assessment of Eastern Nigerian patients with community-acquired pneumonia: a prospective observational study
por: Mbata, Godwin C, et al.
Publicado: (2013)

Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With Radiotherapy
por: Barrón, Feliciano, et al.
Publicado: (2020)

Analysis of the risk factors of radiation pneumonitis in patients after radiotherapy for esophageal squamous cell carcinoma
por: Sun, Lu, et al.
Publicado: (2023)

Chronic immune checkpoint inhibitor pneumonitis
por: Naidoo, Jarushka, et al.
Publicado: (2020)

Pandemic Influenza (H1N1) 2009 Pneumonia: CURB-65 Score for Predicting Severity and Nasopharyngeal Sampling for Diagnosis Are Unreliable
por: Mulrennan, Siobhain, et al.
Publicado: (2010)

Effectiveness of Proadrenomedullin Enhanced CURB65 Score Algorithm in Patients with Community-Acquired Pneumonia in “Real Life”, an Observational Quality Control Survey
por: Widmer, Daniel, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_14q1g35ropl6ve4hficviqvfon